RESUMO
BACKGROUND: Sunitinib is approved worldwide for treatment of advanced pancreatic neuroendocrine tumours (pNET), but no validated markers exist to predict response. This analysis explored biomarkers associated with sunitinib activity and clinical benefit in patients with pNET and carcinoid tumours in a phase II study. METHODS: Plasma was assessed for vascular endothelial growth factor (VEGF)-A, soluble VEGF receptor (sVEGFR)-2, sVEGFR-3, interleukin (IL)-8 (n=105), and stromal cell-derived factor (SDF)-1α (n=28). Pre-treatment levels were compared between tumour types and correlated with response, progression-free (PFS), and overall survival (OS). Changes in circulating myelomonocytic and endothelial cells were also analysed. RESULTS: Stromal cell-derived factor-1α and sVEGFR-2 levels were higher in pNET than in carcinoid (P=0.003 and 0.041, respectively). High (above-median) baseline SDF-1α was associated with worse PFS, OS, and response in pNET, and high sVEGFR-2 with longer OS (P⩽0.05). For carcinoid, high IL-8, sVEGFR-3, and SDF-1α were associated with shorter PFS and OS, and high IL-8 and SDF-1α with worse response (P⩽0.05). Among circulating cell types, monocytes showed the largest on-treatment decrease, particularly CD14+ monocytes co-expressing VEGFR-1 or CXCR4. CONCLUSIONS: Interleukin-8, sVEGFR-3, and SDF-1α were identified as predictors of sunitinib clinical outcome. Putative pro-tumorigenic CXCR4+ and VEGFR-1+ monocytes represent novel candidate markers and biologically relevant targets explaining the activity of sunitinib.
Assuntos
Antineoplásicos/uso terapêutico , Biomarcadores Tumorais/sangue , Citocinas/sangue , Indóis/uso terapêutico , Monócitos/patologia , Tumores Neuroendócrinos/sangue , Tumores Neuroendócrinos/tratamento farmacológico , Pirróis/uso terapêutico , Biomarcadores Tumorais/imunologia , Tumor Carcinoide/sangue , Tumor Carcinoide/tratamento farmacológico , Tumor Carcinoide/imunologia , Citocinas/imunologia , Intervalo Livre de Doença , Feminino , Humanos , Contagem de Leucócitos , Monócitos/imunologia , Tumores Neuroendócrinos/imunologia , Sunitinibe , Resultado do TratamentoRESUMO
Spinocerebellar ataxia type 10 (SCA10; MIM 603516; refs 1,2) is an autosomal dominant disorder characterized by cerebellar ataxia and seizures. The gene SCA10 maps to a 3.8-cM interval on human chromosome 22q13-qter (refs 1,2). Because several other SCA subtypes show trinucleotide repeat expansions, we examined microsatellites in this region. We found an expansion of a pentanucleotide (ATTCT) repeat in intron 9 of SCA10 in all patients in five Mexican SCA10 families. There was an inverse correlation between the expansion size, up to 22.5 kb larger than the normal allele, and the age of onset (r2=0.34, P=0.018). Analysis of 562 chromosomes from unaffected individuals of various ethnic origins (including 242 chromosomes from Mexican persons) showed a range of 10 to 22 ATTCT repeats with no evidence of expansions. Our data indicate that the new SCA10 intronic ATTCT pentanucleotide repeat in SCA10 patients is unstable and represents the largest microsatellite expansion found so far in the human genome.
Assuntos
Cromossomos Humanos Par 22 , DNA/genética , Sequências Repetitivas de Ácido Nucleico , Ataxias Espinocerebelares/genética , Animais , Povo Asiático/genética , Encéfalo/metabolismo , Encéfalo/patologia , Mapeamento Cromossômico , DNA/sangue , DNA/química , Epilepsia/genética , Epilepsia/patologia , Feminino , Humanos , Masculino , Americanos Mexicanos/genética , Camundongos , Camundongos Endogâmicos C57BL , Dados de Sequência Molecular , Linhagem , Polimorfismo Genético , Ataxias Espinocerebelares/patologia , Estados Unidos , População Branca/genéticaRESUMO
BACKGROUND: We investigated cytokines and angiogenic factors (CAFs) in patients with metastatic renal cell carcinoma (mRCC) treated in a randomized phase II clinical trial of sorafenib versus sorafenib+ interferon-α (IFN-α) that yielded no differences in progression-free survival (PFS). We aimed to link the CAF profile to PFS and select candidate predictive and prognostic markers for further study. METHODS: The concentrations of 52 plasma CAFs were measured pretreatment (n = 69), day 28, and day 56 using multiplex bead arrays and enzyme-linked immunosorbent assay. We investigated the association between baseline levels of CAFs with PFS and posttreatment changes. RESULTS: Unsupervised CAF clustering analysis revealed two distinct mRCC patient groups with elevated proangiogenic or proinflammatory mediators. A six-marker baseline CAF signature [osteopontin, vascular endothelial growth factor (VEGF), carbonic anhydrase 9, collagen IV, VEGF receptor-2, and tumor necrosis factor-related apoptosis-inducing ligand] correlated with PFS benefit (hazard ratio 0.20 versus 2.25, signature negative versus positive, respectively; P = 0.0002). While changes in angiogenic factors were frequently attenuated by the sorafenib+ IFN combination, most key immunomodulatory mediators increased. CONCLUSIONS: Using CAF profiling, we identified two mRCC patient groups, a candidate plasma signature for predicting PFS benefit, and distinct marker changes occurring with each treatment. This platform may provide valuable insights into renal cell carcinoma biology and the molecular consequences of targeted therapies.
Assuntos
Biomarcadores Tumorais/sangue , Carcinoma de Células Renais/sangue , Citocinas/sangue , Neoplasias Renais/sangue , Fator A de Crescimento do Endotélio Vascular/sangue , Antineoplásicos/uso terapêutico , Benzenossulfonatos/uso terapêutico , Carcinoma de Células Renais/tratamento farmacológico , Carcinoma de Células Renais/mortalidade , Análise por Conglomerados , Intervalo Livre de Doença , Ensaio de Imunoadsorção Enzimática , Humanos , Interferon-alfa/administração & dosagem , Estimativa de Kaplan-Meier , Neoplasias Renais/tratamento farmacológico , Neoplasias Renais/mortalidade , Niacinamida/análogos & derivados , Compostos de Fenilureia , Piridinas/uso terapêutico , SorafenibeRESUMO
BACKGROUND: Wolff-Parkinson-White syndrome (WPW) is a bypass re-entrant tachycardia that results from an abnormal connection between the atria and ventricles. Mutations in PRKAG2 have been described in patients with familial WPW syndrome and hypertrophic cardiomyopathy. Based on the role of bone morphogenetic protein (BMP) signalling in the development of annulus fibrosus in mice, it has been proposed that BMP signalling through the type 1a receptor and other downstream components may play a role in pre-excitation. METHODS AND RESULTS: Using the array comparative genomic hybridisation (CGH), we identified five individuals with non-recurrent deletions of 20p12.3. Four of these individuals had WPW syndrome with variable dysmorphisms and neurocognitive delay. With the exception of one maternally inherited deletion, all occurred de novo, and the smallest of these harboured a single gene, BMP2. In two individuals with additional features of Alagille syndrome, deletion of both JAG1 and BMP2 were identified. Deletion of this region has not been described as a copy number variant in the Database of Genomic Variants and has not been identified in 13 321 individuals from other cohort examined by array CGH in our laboratory. CONCLUSIONS: Our findings demonstrate a novel genomic disorder characterised by deletion of BMP2 with variable cognitive deficits and dysmorphic features and show that individuals bearing microdeletions in 20p12.3 often present with WPW syndrome.
Assuntos
Proteína Morfogenética Óssea 2/genética , Transtornos Cognitivos/genética , Deleção de Sequência , Síndrome de Wolff-Parkinson-White/genética , Adulto , Síndrome de Alagille/genética , Animais , Proteínas de Ligação ao Cálcio/genética , Hibridização Genômica Comparativa , Eletrocardiografia , Fácies , Feminino , Dosagem de Genes , Humanos , Lactente , Peptídeos e Proteínas de Sinalização Intercelular/genética , Proteína Jagged-1 , Masculino , Proteínas de Membrana/genética , Camundongos , Camundongos Transgênicos , Análise de Sequência com Séries de Oligonucleotídeos , Proteínas Serrate-Jagged , Síndrome de Wolff-Parkinson-White/patologiaRESUMO
Mutations in ROR2, encoding a receptor tyrosine kinase, can cause autosomal recessive Robinow syndrome (RRS), a severe skeletal dysplasia with limb shortening, brachydactyly, and a dysmorphic facial appearance. Other mutations in ROR2 result in the autosomal dominant disease, brachydactyly type B (BDB1). No functional mechanisms have been delineated to effectively explain the association between mutations and different modes of inheritance causing different phenotypes. BDB1-causing mutations in ROR2 result from heterozygous premature termination codons (PTCs) in downstream exons and the conveyed phenotype segregates as an autosomal dominant trait, whereas heterozygous missense mutations and PTCs in upstream exons result in carrier status for RRS. Given that the distribution of PTC mutations revealed a correlation between the phenotype and the mode of inheritance conveyed, we investigated the potential role for the nonsense-mediated decay (NMD) pathway in the abrogation of possible aberrant effects of selected mutant alleles. Our experiments show that triggering or escaping NMD may cause different phenotypes with a distinct mode of inheritance. We generalize these findings to other disease-associated genes by examining PTC mutation distribution correlation with conveyed phenotype and inheritance patterns. Indeed, NMD may explain distinct phenotypes and different inheritance patterns conveyed by allelic truncating mutations enabling better genotype-phenotype correlations in several other disorders.
Assuntos
Anormalidades Múltiplas/genética , Alelos , Genes Dominantes , Genes Recessivos , Padrões de Herança , Mutação , Doenças do Desenvolvimento Ósseo/genética , Células Cultivadas , Humanos , Deformidades Congênitas dos Membros/genética , Fenótipo , Receptores Órfãos Semelhantes a Receptor Tirosina Quinase , Receptores de Superfície Celular/genética , SíndromeRESUMO
BACKGROUND: Perivalvular and valve involvement are prevalent in patients with end-stage renal disease (ESRD), especially in younger patients compared with normal population. Kidney transplantation improves the prognosis of these patients. Patients with cardiac valvular disease is also be improved following kidney transplantation. OBJECTIVE: To evaluate the impact of renal transplantation on the severity of mitral regurgitation (MR). METHODS: We studied 95 kidney transplantation candidates in Sina Hospital. The patients underwent echocardiography preoperatively and at the 3rd, 6th, and 12th months post-operatively. RESULTS: Pre-operatively, the average MR fraction was 30%; MR volume 30 mL/beat; mitral valve mean gradient 1.8 mm Hg; mitral valve area 4.6 cm2; and mitral annular size 3 cm. No significant difference was observed among the measurements made at the 3rd, 6th, and 12th months post-operatively. CONCLUSION: There was no significant association between the variables measured pre- and post-operatively. The reason might be the fact that patients with ESRD in Iran do not have to expect long transplant waiting lists and dialysis cannot affect their heart adversely.
RESUMO
BACKGROUND: Reperfusion injury and the acid-base status of the transplant are important factors affecting post-transplantation graft function. OBJECTIVE: We hypothesized that infusing hypertonic saline (HS) or tight control of acid-base status of the blood rushing through renal graft using sodium bicarbonate may have beneficial effects on early graft function. METHODS: Candidates for deceased-donor kidney transplant were randomized into three groups. HS group (n=33) received 50 mL/kg normal saline (NS) titrated during operation plus 4 mL/kg of 5% HS just within graft reperfusion phase; bicarbonate group (n=37) was administered 60 mL/kg NS while their metabolic acidosis (base excess ≤5 mEq/L) was tightly corrected every 30 min with sodium bicarbonate; and a control group (n=36) that received 60 mL/kg normal saline while they were administered sodium bicarbonate only, if they encountered severe metabolic acidosis (base excess ≤15 mEq/L). The primary outcome was defined as early post-operative renal function evaluated based on serial serum creatinine levels. The study was registered in Iranian Registry of Clinical Trials (IRCT2013122815841N19). RESULTS: Post-operative early graft function improved significantly during the first 3 days in the intervention groups (p<0.05). However, that beneficial effect no longer remained at the same level after the day four. CONCLUSION: Timely administration of HS or tight control of metabolic acidosis with sodium bicarbonate infusion improve early renal function during renal transplant surgery.
RESUMO
We reviewed our experience with 21 patients who had Cushing's disease due to ACTH-secreting macroadenomas to clarify the natural history of this disease. All patients had typical clinical and biochemical features of ACTH-dependent hypercortisolism. Their mean maximal tumor diameter was 1.6 +/- 0.1 cm, and the range was 1.0-2.7 cm. Six patients had cavernous sinus invasion, three had invasion of the floor of their sella, and nine had suprasellar extension. The observed remission rate was significantly lower in macroadenoma patients than in microadenoma patients (67% vs. 91%; chi 2 = 5.7; P < 0.02). Cavernous sinus invasion (odds ratio, 35; 95% confidence interval, 2.6-475; P < 0.008) and presence of a maximum tumor diameter 2.0 cm or more (odds ratio, 12.9; 95% confidence interval, 1.4-124; P < 0.02) emerged as the only predictors of residual disease after surgery. The observed recurrence rate was significantly higher in macroadenoma patients than in microadenoma patients (36% vs. 12%; chi 2 = 4.2; P < 0.05). Macroadenoma patients tended to suffer from recurrences earlier than did microadenoma patients (16 vs. 49 months). Stepwise multiple logistic regression did not identify any predictors of disease recurrence in macroadenoma patients. Eight macroadenoma patients underwent a total of nine repeat surgical procedures, but none of these resulted in clinical remissions. Only four of seven (57%) patients followed for a sufficient period of time achieved normal urinary free cortisol levels after conventional radiotherapy. Three (75%) of these four patients had re-recurrent hypercortisolism after brief periods of eucortisolism. Pharmacological agents and adrenalectomy were effective in the management of hypercortisolism in patients with residual and recurrent disease. Our results indicate that ACTH-secreting macroadenomas are more refractory to conventional treatments than are ACTH-secreting microadenomas.
Assuntos
Adenoma/cirurgia , Hormônio Adrenocorticotrópico/metabolismo , Síndrome de Cushing/etiologia , Síndrome de Cushing/terapia , Neoplasias Hipofisárias/cirurgia , Adenoma/metabolismo , Adenoma/patologia , Adenoma/radioterapia , Adulto , Terapia Combinada , Intervalos de Confiança , Bases de Dados Factuais , Intervalo Livre de Doença , Feminino , Seguimentos , Humanos , Hidrocortisona/sangue , Masculino , Invasividade Neoplásica , Recidiva Local de Neoplasia , Razão de Chances , Neoplasias Hipofisárias/metabolismo , Neoplasias Hipofisárias/patologia , Neoplasias Hipofisárias/radioterapia , Análise de Regressão , Reoperação , Estudos Retrospectivos , Fatores de TempoRESUMO
OBJECTIVE: To determine whether the G-to-A substitution at nucleotide 209 (G209A) mutation in the alpha-synuclein gene is responsible for familial Parkinson disease (PD) in the US population. DESIGN: Polymerase chain reaction-based DNA analysis of consecutive patients with PD and family history of PD. SETTING: A university-affiliated movement disorder clinic and a Veterans Affairs clinical research laboratory. PATIENTS: Forty-four patients with PD and family history of PD and 29 patients with sporadic PD, all with no known Greek and/or Italian background. RESULTS: None of the DNA samples showed the G209A mutation. CONCLUSION: The G209A mutation is rare in US patients with familial PD.
Assuntos
Proteínas do Tecido Nervoso/genética , Doença de Parkinson/etnologia , Doença de Parkinson/genética , Mutação Puntual/genética , Adulto , Idoso , Análise Mutacional de DNA , Feminino , Grécia/etnologia , Humanos , Itália/etnologia , Masculino , Pessoa de Meia-Idade , Reação em Cadeia da Polimerase , Sinucleínas , Estados Unidos/epidemiologia , alfa-SinucleínaRESUMO
BACKGROUND: In recent years, interest in gene-environment interactions has spurred a great number of association studies on polymorphism of different genes. OBJECTIVE: To review case-control studies of genetic polymorphisms in PD, and perform meta-analysis of individual gene polymorphism. METHODS: The authors searched the Medline database (PubMed) for publications (English language) from January 1966 to November 1999 for association studies in PD. The key words used were "PD" and "polymorphism." The authors supplemented the search with relevant references quoted in these published articles. Those with four or more independent studies of a specific gene polymorphism were subjected to meta-analysis, with the exception of cytochrome-P450 enzyme polymorphisms, for which meta-analyses results were already available in the literature. RESULTS: The authors identified 84 studies on 14 genes, including dopamine receptors (DRD2 and DRD4), dopamine transporter (DAT), monoamine oxidase (MAOA and MAOB), catechol-O-methyltransferase (COMT), N-acetyltransferase 2 (NAT2), APOE, glutathione transferase (GSTT1, GSTM1, GSTP1, and GSTZ1), and mitochondrial genes (tRNAGlu and ND2). Four polymorphisms showed significant association with PD: slow acetylator genotypes of NAT2 (PD:control OR = 1.36), allele >188bp of the MAOB (GT)n polymorphism (OR = 2.58), the deletion allele of GSTT1 (OR = 1.34), and A4336G of tRNAGlu (OR = 3.0). No significant differences were found for the other genes. CONCLUSION: Significant associations with PD were found in polymorphisms of NAT2, MAOB, GSTT1, and tRNAGlu. Although significant association does not imply a causal relationship between the presence of the polymorphisms and PD pathogenesis, their pathophysiologic significance should be studied further.
Assuntos
Variação Genética/genética , Glicoproteínas de Membrana , Proteínas de Membrana Transportadoras , Proteínas do Tecido Nervoso , Doença de Parkinson/genética , Polimorfismo Genético/genética , Apolipoproteínas E/genética , Arilamina N-Acetiltransferase/genética , Proteínas de Transporte/genética , Estudos de Casos e Controles , Catecol O-Metiltransferase/genética , DNA Mitocondrial/genética , Proteínas da Membrana Plasmática de Transporte de Dopamina , Feminino , Frequência do Gene , Ligação Genética , Glutationa Transferase/genética , Humanos , Isoenzimas/genética , Masculino , Monoaminoxidase/genética , RNA de Transferência de Ácido Glutâmico/genética , Receptores de Dopamina D2/genética , Receptores de Dopamina D4 , Reprodutibilidade dos TestesRESUMO
OBJECTIVES: To identify the disease-causing mutation and its molecular consequence for a clinically distinct type of myotonic myopathy. BACKGROUND: The authors encountered a unique myotonic disorder of early onset in a 37-year-old man and his 47-year-old sister. METHODS: After examining known loci of inherited myotonic disorders, the authors looked for mutations within the CLCN1 gene using single strand conformation polymorphism and direct sequencing. To investigate the disease mechanism, reverse transcriptase PCR analyses of total RNA were performed. RESULTS: In the proband and his affected sister, two novel mutations comprising a compound heterozygous state in the CLCN1 gene were identified: 1) a base (G) insertion in exon 7 generating a premature termination codon (fs289X) in the D5 domain, and 2) a C-to-T substitution in exon 23 resulting in a missense mutation (P932L). These mutations accompanied a clinical phenotype that is distinguishable from recessive myotonia congenita by progressive generalized muscle weakness, severe distal muscle atrophy, joint contractures, high serum creatine kinase levels, and conspicuous myopathic changes on muscle histopathology. Reverse transcriptase PCR analyses detected only the P932L mutant mRNA in skeletal muscle, suggesting that the fs289X mRNA is degraded rapidly. CONCLUSIONS: These data suggest that fs289X is a null mutation, rendering the patients with the compound heterozygous genotype of fs289X/P932L to exclusively express P932L homomeric channels that may have caused the "dystrophic" phenotype.
Assuntos
Canais de Cloreto/genética , Mutação/genética , Miotonia Congênita/genética , Adulto , Humanos , Masculino , Fenótipo , Reação em Cadeia da PolimeraseRESUMO
An allele (263bp) of the nonamyloid component of plaques (NACP)-Repl polymorphism has shown association with sporadic PD in a German population. The authors studied this polymorphism in 100 American PD patients and 100 healthy controls. The authors also studied 46 essential tremor (ET) and 55 Huntington's disease (HD) patients. Allele 263bp was significantly higher in PD patients (OR = 3.86) and ET patients (OR = 6.42) but not HD patients, compared with healthy controls. The association of allele 263bp with PD and ET suggests a possible etiologic link between these two conditions.
Assuntos
Tremor Essencial/genética , Proteínas do Tecido Nervoso/genética , Doença de Parkinson/genética , Polimorfismo Genético/genética , Adulto , Idade de Início , Idoso , Idoso de 80 Anos ou mais , Alelos , Tremor Essencial/complicações , Feminino , Genótipo , Humanos , Masculino , Pessoa de Meia-Idade , Doença de Parkinson/complicações , SinucleínasRESUMO
A particular alcohol dehydrogenase (ADH) polymorphism (allele A1) in the promoter region of the gene has been recently demonstrated to be associated with increased risk of Parkinson's disease (PD). In a case control study, we examine frequencies of ADH A1 allele in 100 PD patients (i.e. 200 alleles), 100 diseased controls (i.e. 200 alleles), and 194 healthy controls (i.e. 388 alleles). In addition, we study possible association of a combined non-amyloid component of plaque (NACP-Rep 1) allele and ADH A1 allele with risk of PD. There was no statistical significance of the frequencies of ADH A1 allele between PD patients 12/200 (6%), diseased controls 13/200 (6.5%), and healthy controls 20/388 (5.2%). No strong evidence of an association was found between ADH A1 allele and PD susceptibility in our study patients. There was also no suggestion of linkage disequilibrium between NACP-Rep 1 and ADH A1 alleles.
Assuntos
Álcool Desidrogenase/genética , Isoenzimas/genética , Doença de Parkinson/genética , Polimorfismo Genético/fisiologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Alelos , Estudos de Casos e Controles , Frequência do Gene , Predisposição Genética para Doença , Humanos , Doença de Huntington/genética , Desequilíbrio de Ligação , Pessoa de Meia-Idade , Valores de Referência , Tremor/genéticaAssuntos
Complicações do Diabetes , Cetoacidose Diabética , Coma Hiperglicêmico Hiperosmolar não Cetótico , Cetoacidose Diabética/diagnóstico , Cetoacidose Diabética/etiologia , Cetoacidose Diabética/terapia , Eletrólitos/uso terapêutico , Humanos , Coma Hiperglicêmico Hiperosmolar não Cetótico/diagnóstico , Coma Hiperglicêmico Hiperosmolar não Cetótico/etiologia , Coma Hiperglicêmico Hiperosmolar não Cetótico/terapia , Insulina/administração & dosagemRESUMO
BACKGROUND: This study was designed to assess the effectiveness of a series of journal clubs held for anesthesiology residents in promoting their awareness of research methods and statistical analysis, as well as their skills in critical thinking and appraisal. MATERIAL AND METHODS: Twenty-four journal club sessions were held between September 2006 and August 2007 for 16 residents of anesthesiology. A 31 multiple-choice question (MCQ) was taken as pretest and posttest to evaluate the participants' level of awareness in research methodology and statistical analysis. Their competence in critical thinking and appraisal was also evaluated by evaluating a randomized controlled trial paper using the CONSORT checklist before and after the course. RESULTS: Residents' awareness in the application of information improved (P = 0.012), as well as research methodology (combined study design and application of information, P = 0.017). Their ability in critical appraisal did also significantly rise at the end of the course (P < 0.001). CONCLUSION: Journal clubs can enable residents to develop the knowledge, expertise and enthusiasm needed to undertake research plans and can also enhance their ability in critical thinking and scientific reading.
Assuntos
Anestesiologia/educação , Educação Baseada em Competências/métodos , Internato e Residência/métodos , Publicações Periódicas como Assunto , Ensino/métodos , Pensamento , Conhecimentos, Atitudes e Prática em Saúde , Humanos , Leitura , Projetos de PesquisaRESUMO
1. An experiment was carried out to evaluate the effect of early feed restriction (FR) on immunocompetence of Ross and Arian chickens with separated sexes under heat stress (HS) conditions. 2. Chickens consumed feed ad libitum (AL) or were restricted on alternate days from 11 to 20 d of age. From 35 to 41 d of age, the HS groups were exposed to a high ambient temperature of 39 +/- 1 degreesC for 7 h each day, while the thermoneutral groups (TN) were at 33 degrees C. 3. At 21 and 42d of age, the percentage of CD4+ (helper T cells) and CD8+ (cytotoxic T cells) were determined by flow cytometry. Antibody response to sheep red blood cells (SRBC) and heterophil/lymphocyte (H/L) ratio were determined on d 21 and 42. 4. On d 21, FR elevated the CD4+, antibody titre and H/L ratio, but it decreased the CD8+ T cells. On d 42, HS decreased CD4+, CD8+, and antibody titre, but it increased H/L ratio. Under TN conditions, FR chickens had higher CD4+ than AL chickens. On d 42, FR/HS chickens had higher CD4+ and antibody titre, but they had lower CD8+ and H/L ratio than AL/HS chickens. 5. On d 42, the TN-Ross strain had lower CD4+, but they had higher CD8+ and antibody titres than the TN-Arian strain. On d 42, the HS-Arian strain had higher antibody titres and a lower H/L ratio than the HS-Ross strain. 6. Male chickens had higher CD4+, CD8+, antibody titres and H/L ratios 25 in all treatment groups. 7. In conclusion, FR early in life reduced some of the negative effects of the heat stress on the immune system of broiler chickens when exposed to high environmental temperatures later in life.
Assuntos
Galinhas/imunologia , Privação de Alimentos/fisiologia , Temperatura Alta , Imunocompetência , Envelhecimento/imunologia , Envelhecimento/fisiologia , Animais , Anticorpos/sangue , Formação de Anticorpos , Contagem de Linfócito CD4/veterinária , Relação CD4-CD8/veterinária , Galinhas/fisiologia , Feminino , Citometria de Fluxo/veterinária , Temperatura Alta/efeitos adversos , Imunidade Celular , Contagem de Leucócitos/veterinária , Leucócitos , Masculino , Distribuição Aleatória , Fatores SexuaisRESUMO
We investigated a family with a new type of autosomal dominant cerebellar ataxia (ADCA) in which pure cerebellar ataxia is often accompanied with epilepsy. No CAG repeat expansions were detected at the spinocerebellar ataxia (SCA) type 1, 2, 3, 6, or 7 locus, and SCAs 4 and 5 were excluded by linkage analysis. We found linkage between the disease locus and D22S274 (Zmax = 3.86 at theta = 0.00) and two other makers in 22q13-qter. Haplotype analysis of the crossover events and the multipoint linkage mapping localized the disease locus to an 8.8-cM region between D22S1177 and D22S1160.
Assuntos
Mapeamento Cromossômico , Cromossomos Humanos Par 22/genética , Epilepsia/genética , Degenerações Espinocerebelares/genética , Feminino , Ligação Genética , Genótipo , Humanos , Masculino , Linhagem , FenótipoRESUMO
In myotonic dystrophy type 1 (DM1), an expanded CTG repeat shows repeat size instability in somatic and germ line tissues with a strong bias toward further expansion. To investigate the mechanism of this expansion bias, 29 DM1 and six normal lymphoblastoid cell lines (LBCLs) were single-cell cloned from blood cells of 18 DM1 patients and six normal subjects. In all 29 cell lines, the expanded CTG repeat alleles gradually shifted toward further expansion by "step-wise" mutations. Of these 29 cell lines, eight yielded a rapidly proliferating mutant with a gain of large repeat size that became the major allele population, eventually replacing the progenitor allele population. By mixing cell lines with different repeat expansions, we found that cells with larger CTG repeat expansion had a growth advantage over those with smaller expansions in culture. This growth advantage was attributable to increased cell proliferation mediated by Erk1,2 activation, which is negatively regulated by p21(WAF1). This phenomenon, which we designated "mitotic drive" , is a novel mechanism which can explain the expansion bias of DM1 CTG repeat instability at the tissue level, on a basis independent of the DNA-based expansion models. The lifespans of the DM1 LBCLs were significantly shorter than normal cell lines. Thus, we propose a hypothesis that DM1 LBCLs drive themselves to extinction through a process related to increased proliferation.